Effect of Enteral Insulin on Time to Reach Full Enteral Feeding in Preterm Infants ≤ 32 weeks and ≤ 1250 grams: A Randomised Controlled Trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 116
- 试验地点
- 1
- 主要终点
- Time to reach full enteral feeding defined as total enteral intake of 180 ml/kg/day tolerated for 48 hours
研究概览
简要总结
This is a randomised controlled trial to study the effect of enteral insulin on time to reach full enteral feeding in preterm infants ≤ 32 weeks and ≤ 1250 grams. Preterm infants have an immature gut, reduced digestive capacity and poor intestinal motility. This leads to an increase in the time to reach full enteral feeding, thereby increasing the duration of parenteral nutrition, length of hospital stay and risk of sepsis. insulin present in breast milk is known to have a beneficial influence on maturation of gut. Insulin when supplemented orally, has a local effect on gut mucosa and helps in enterocyte proliferation, increased enzyme activity and improved absoprtive capacity of gut. Two randomised controlled trials on enteral insulin have reported benefits in terms of decreased time to reach full enteral feeding, improved feeding tolerance and decrease in duration of parenteral nutrition. These benefits could further translate in reduction in rates of sepsis and other PN associated complications. this can have important implications in the developing countries where this strategy has not been studied. we plan to conduct a randomised controlled trial to study the effect of enteral insulin on time to reach full enteral feeding in preterm infants ≤ 32 weeks gestation and ≤ 1250 gram birth weight. eligible infants will be randomly allocated into two groups, Group A (enteral insulin group) and group B (placebo group). we hypothesize that enteral insulin therapy compared to placebo will decrease time to reach full enteral feeding in preterm infants ≤ 32 weeks gestation and ≤ 1250 gram birth weight by 2.5 days. Our primary objective is to compare the time to reach full enteral feeding defined as feeding volume of 180 ml/kg/day tolerated for 48 hours, in enteral versus placebo group. Our secondary objectives are time to reach enteral intake of 100ml/kg/day, duration of parenteral nutrition, episodes of feeding intolerance, time taken to regain birth weight, incidence of culture positive sepsis, incidence of necrotising enterocolitis, episodes of hypoglycemia, growth velocity at stoppage of intervention and at discharge for weight, length and head circumference, duration of hospital stay and all cause mortality
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Investigator Blinded
入排标准
- 年龄范围
- 1.00 Day(s) 至 60.00 Day(s)(—)
- 性别
- All
入选标准
- •preterm infants ≤ 32 weeks of gestation and ≤ 1250 gram in whom enteral feed is being initiated.
排除标准
- •gestational age less than 26 weeks or birth weight less than 500 gram suspected GI malformations maternal diabetes hypoglycemia requiring glucose administration of more than 12mg/kg/min in first 72 hours of life failure to obtain consent.
结局指标
主要结局
Time to reach full enteral feeding defined as total enteral intake of 180 ml/kg/day tolerated for 48 hours
时间窗: Day of life when baby reaches feeds to 180 ml/kg/day which baby has tolerated for 48 hours
次要结局
- Time taken to reach enteral intake of 100 ml/kg/day tolerated for 48 hours(Duration of parenteral nutrition)
研究者
Dr Neelam Kler
Sir Gangaram Hospital, NewDelhi
